Synopsis
Synopsis
0
USDMF
0
KDMF
0
NDC API
0
VMF
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Akineton
2. Alpha-bicyclo(2.2.1)hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol
3. Biperiden
4. Biperiden, 1r-(1 Alpha,2 Alpha(r*),4 Alpha)-isomer
5. Biperiden, 1s-(1 Alpha,2 Alpha(r*),4 Alpha)-isomer
6. Biperidene
7. Hydrochloride, Biperiden
1. 1235-82-1
2. Akineton
3. Akinophyl
4. Biperiden Hcl
5. Biperiden (hydrochloride)
6. Akineton Hydrochloride
7. Biperidine Hydrochloride
8. Tasmolin
9. Kl 373 (hydrochloride)
10. Biperidene Hydrochloride
11. Nsc-84989
12. Nsc-170950
13. K35n76cuhf
14. 1-bicycloheptenyl-1-phenyl-3-piperidinopropanol-1 Hydrochloride
15. Tasmolin (tn)
16. 1-(2-bicyclo[2.2.1]hept-5-enyl)-1-phenyl-3-piperidin-1-ylpropan-1-ol;hydrochloride
17. Dsstox_cid_27832
18. Dsstox_rid_82595
19. Dsstox_gsid_47856
20. 1-piperidinepropanol, Alpha-bicyclo[2.2.1]hept-5-en-2-yl-alpha-phenyl-, Hydrochloride (1:1)
21. Akineton, Hydrochloride
22. Chebi:59171
23. Smr001456154
24. Wln: L55 A Cutj Fxqr&2- At6ntj &gh
25. Ncgc00182965-01
26. Einecs 214-976-2
27. Nsc 84989
28. Unii-k35n76cuhf
29. Nsc 170950
30. Sr-05000001649
31. .alpha.-5-norbornen-2-yl-.alpha.-phenyl-piperidinepropanol Hydrochloride
32. .alpha.-[bicyclo[2.2.1]hept-5-en-2-yl]-.alpha.-phenyl-1-piperidinepropanol Hydrochloride
33. Prestwick_839
34. Biperiden Hydrochloride [usp:ban:jan]
35. Biperideni Hydrochloridum
36. 1-piperidinepropanol, .alpha.-bicyclo(2.2.1)hept-5-en-2-yl-.alpha.-phenyl-, Hydrochloride
37. Alpha-5-norbornen-2-yl-alpha-phenyl-1-piperidinepropanol Hydrochloride
38. Cas-1235-82-1
39. 1-piperidinepropanol, Alpha-bicyclo(2.2.1)hept-5-en-2-yl-alpha-phenyl-, Hydrochloride
40. Alpha-(bicyclo(2.2.1)hept-5-en-2-yl)-alpha-phenyl-1-piperidinepropanol Hydrochloride
41. Piperidinepropanol, Alpha-bicyclo(2.2.1)hept-5-en-2-yl-alpha-phenyl-, Hydrochloride
42. Schembl40776
43. Mls003915621
44. Mls006011163
45. Chembl1201035
46. Dtxsid2047856
47. Hms1569f05
48. Nsc84989
49. Biperiden Hydrochloride [mi]
50. Tox21_112785
51. Tox21_113064
52. Tox21_500217
53. Biperiden Hydrochloride (jp17/usp)
54. Biperiden Hydrochloride [jan]
55. Nsc170950
56. 1-piperidinepropanol, Alpha-5-norbornen-2-yl-alpha-phenyl-, Hydrochloride
57. Akos024457314
58. Tox21_112785_1
59. Bcp9000415
60. Biperiden Hydrochloride [mart.]
61. Biperiden Hydrochloride [vandf]
62. Ccg-221521
63. Cs-0442
64. Lp00217
65. 1-(5-bicyclo[2.2.1]hept-2-enyl)-1-phenyl-3-(1-piperidinyl)propan-1-ol Hydrochloride
66. Biperiden Hydrochloride [who-dd]
67. Biperiden Hydrochloride [who-ip]
68. Ncgc00182965-05
69. Ncgc00260902-01
70. Hy-13204
71. Biperiden Hydrochloride [orange Book]
72. Sw196970-2
73. Biperiden Hydrochloride [ep Monograph]
74. Biperiden Hydrochloride [usp Impurity]
75. D02246
76. Biperiden Hydrochloride, >=98% (hplc), Powder
77. Biperideni Hydrochloridum [who-ip Latin]
78. J-004957
79. Sr-05000001649-3
80. Q27126508
81. 1-bicyclo[2.2.1]hept-5-en-2-yl-1-phenyl-3-piperidin-1-ylpropan-1-ol Hcl
82. .alpha.-5-norbornen-2-yl-.alpha.-phenyl-1-piperidinepropanol Hydrochloride
83. 1-(bicyclo[2.2.1]hept-5-en-2-yl)-1-phenyl-3-(piperidin-1-yl)propan-1-olhydrochloride
| Molecular Weight | 347.9 g/mol |
|---|---|
| Molecular Formula | C21H30ClNO |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 5 |
| Exact Mass | 347.2015923 g/mol |
| Monoisotopic Mass | 347.2015923 g/mol |
| Topological Polar Surface Area | 23.5 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 422 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 4 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Antiparkinson Agents
Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)
Muscarinic Antagonists
Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)
Parasympatholytics
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Biperiden Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Biperiden Hydrochloride, including repackagers and relabelers. The FDA regulates Biperiden Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Biperiden Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Biperiden Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Biperiden Hydrochloride supplier is an individual or a company that provides Biperiden Hydrochloride active pharmaceutical ingredient (API) or Biperiden Hydrochloride finished formulations upon request. The Biperiden Hydrochloride suppliers may include Biperiden Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Biperiden Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Biperiden Hydrochloride Drug Master File in Japan (Biperiden Hydrochloride JDMF) empowers Biperiden Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Biperiden Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Biperiden Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Biperiden Hydrochloride suppliers with JDMF on PharmaCompass.
A Biperiden Hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Biperiden Hydrochloride Certificate of Suitability (COS). The purpose of a Biperiden Hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Biperiden Hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Biperiden Hydrochloride to their clients by showing that a Biperiden Hydrochloride CEP has been issued for it. The manufacturer submits a Biperiden Hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Biperiden Hydrochloride CEP holder for the record. Additionally, the data presented in the Biperiden Hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Biperiden Hydrochloride DMF.
A Biperiden Hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Biperiden Hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Biperiden Hydrochloride suppliers with CEP (COS) on PharmaCompass.
A Biperiden Hydrochloride written confirmation (Biperiden Hydrochloride WC) is an official document issued by a regulatory agency to a Biperiden Hydrochloride manufacturer, verifying that the manufacturing facility of a Biperiden Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Biperiden Hydrochloride APIs or Biperiden Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Biperiden Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Biperiden Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
Biperiden Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Biperiden Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Biperiden Hydrochloride GMP manufacturer or Biperiden Hydrochloride GMP API supplier for your needs.
A Biperiden Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Biperiden Hydrochloride's compliance with Biperiden Hydrochloride specifications and serves as a tool for batch-level quality control.
Biperiden Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Biperiden Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Biperiden Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Biperiden Hydrochloride EP), Biperiden Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Biperiden Hydrochloride USP).
LOOKING FOR A SUPPLIER?
